BioHarvest Sciences Inc. announced on January 22, 2025, the appointment of Mr. Sharon Malka as an independent director to its Board of Directors. Mr. Malka brings extensive leadership experience from international healthcare and technology companies.
Sharon Malka currently serves as CEO of Dotz Nano Ltd. and is a board member of Nasdaq-listed MediWound Limited, where he previously held roles as CFO and CEO. His background includes expertise in advancing innovative technologies, structuring strategic transactions, and managing major financing rounds.
Dr. Zaki Rakib, Chairman of the Board, stated that Mr. Malka's operational experience will be invaluable to BioHarvest during its current and future growth stages. CEO Ilan Sobel added that Malka's perspective and experience will be very valuable as the company scales its Botanical Synthesis technology and expands operations.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.